BRAINSTORM CELL THERAPEUTICS INC. (19)
Browse by Contract Category
Contracts
-
Separation Agreement, effective January 20, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Ralph Kern
(Filed With SEC on January 4, 2023)
-
Amendment No. 3 to Offer Letter Agreement, dated January 3, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg
(Filed With SEC on January 4, 2023)
-
Amended and Restated Distribution Agreement, dated September 25, 2020, by and among Brainstorm Cell Therapeutics Inc., SVB Leerink LLC and Raymond James & Associates, Inc
(Filed With SEC on September 25, 2020)
-
Securities Purchase Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and AI Fund 1 LLC
(Filed With SEC on March 6, 2020)
-
Amendment No. 2 to Offer Letter Agreement dated September 18, 2022 between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg
(Filed With SEC on September 22, 2022)
-
Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan
(Filed With SEC on March 28, 2022)
-
Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan
(Filed With SEC on November 15, 2021)
-
Offer letter, dated May 26, 2020, by and between Brainstorm Cell Therapeutics Inc. and Stacey Lindborg
(Filed With SEC on February 4, 2021)
-
Offer Letter by and between Brainstorm Cell Therapeutics Inc. and Anthony Waclawski
(Filed With SEC on September 3, 2020)
-
Amendment to Uri Yablonka Employment Agreement
(Filed With SEC on August 5, 2020)
-
Amendment to Chaim Lebovits Employment Agreement
(Filed With SEC on August 5, 2020)
-
Employment Agreement by and between Brainstorm Cell Therapeutics Inc. and David Setboun
(Filed With SEC on April 3, 2020)
-
Distribution Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc
(Filed With SEC on March 6, 2020)
-
Common Stock Purchase Warrant for the purchase of Common Stock, issued March 6, 2020 by Brainstorm Cell Therapeutics Inc. to Abbhi Investments, LLC
(Filed With SEC on March 6, 2020)
-
Offer letter, dated September 5, 2019, by and between Brainstorm Cell Therapeutics Inc. and Preetam Shah
(Filed With SEC on November 14, 2019)
-
Warrant Exercise Agreement
(Filed With SEC on August 2, 2019)
-
Form of Warrant
(Filed With SEC on August 2, 2019)
-
Distribution Agreement, dated June 11, 2019, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc
(Filed With SEC on June 11, 2019)
-
Employment Agreement by and between Brainstorm Cell Therapeutics Inc. and Arturo Araya effective August 28, 2018
(Filed With SEC on March 29, 2019)